01
About
Us
HansBiomed Co. Ltd. headquartered in Seoul, South Korea, which is a globally recognized, publicly listed leader in medical device R&D, manufacturing and sales.
In 2019, the company guided by the principle of legal medical aesthetics, officially launched MINT®Lift—a facial implant product certified by China’s NMPA. This innovative product is designed for implantation in the Superficial Muscular Aponeurotic System (SMAS) and its superficial tissues to effectively correct nasolabial fold wrinkles.
Four Advantages
Facial Lifting Certification
Legally compliant use for your peace of mind
Facial Lifting License
4x Enhanced Lifting And Securing Force
A longer-lasting and more stable effect
4x Lifting Fixing Force
11 International Papers on Facial Lifting Effectiveness
Verified effectiveness of facial lifting
11 International Papers
FacialZoe Targeted Therapy
Effectively solving skin problems
Zone Targeted Therapy
News Center
2024-07-10
MINT Lift - The Future of Beauty | The Successful Conclusion of the 2024 Academic Annual Conference of the Non-Public Aesthetic Medicine & the Aesthetic Line Technology Sub-Committee
From July 5 to 7, 2024, the 2024 Academic Annual Conference and the Third Comprehensive Facial Rejuvenation Treatment Conference……
More Information
2024-11-11
CNP Company Signs Strategic Cooperation Agreement with Korean Academy of Facelift & Contouring - Broadening New Perspectives in Aesthetics and Strengthening International Exchange Cooperation
On November 10, 2024, Beijing CNP International Co.,ltd., the general distributor of MINT®Lift in China, officially signed a deep strategic cooperation agreement with the Korean Academy of Facelift & Contouring at COEX Seoul Convention Center in Seoul, Korea.
More Information
2024-09-26
Blooming Medical Beauty Light | Clinical Trial Launch Meeting for Injectable Cross-linked Sodium Hyaluronate Gel
On September 26th, Anzhen Hospital witnessed an important milestone in the medical technology field - the launch meeting of the Class III HA medical device clinical trial...
More Information
Contact Us
More Information
